Physician profile
Dallas A Lea
NPI 1063420750
$82,122.07
in general payments reported to CMS, 2019-2025
9 companies · $10K in 2025
The $10K reported for 2025 was more than what 98% of Spinal Cord Injury Medicine providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $4,061 · 2021: $20K · 2022: $2,393 · 2023: $4,661 · 2024: $25K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $27K · Travel and Lodging: $6,876 · Consulting Fee: $3,000 · Food and Beverage: $2,728.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27,240.00 |
| Travel and Lodging | $6,876.02 |
| Consulting Fee | $3,000.00 |
| Food and Beverage | $2,727.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $33,229.41 | 2022-2025 | |
| Allergan, INC. | $32,399.89 | 2019-2021 | |
| Merz Pharmaceuticals, LLC | $8,799.57 | 2021-2025 | Xeomin |
| Merz North America, INC. | $7,416.61 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $160.38 | 2023-2025 | Zilretta, Exparel, Iovera |
| Amgen INC. | $40.54 | 2022-2024 | Prolia, Evenity |
| Revance Therapeutics, INC. | $29.69 | 2024 | Daxxify |
| Avanos Medical | $25.54 | 2025 | On-Q Pump and Accessories |
| Depuy Synthes Sales INC. | $20.44 | 2024 | Orthovisc |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dallas Lea listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.